Australia markets closed

Cyclo Therapeutics, Inc. (CYTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2700+0.0400 (+3.25%)
As of 03:32PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,076
1,076
1,376
1,586
903.376
Cost of revenue
84.367
84.367
138.929
156.08
66.398
Gross profit
992.038
992.038
1,237
1,430
836.978
Operating expenses
Research development
14,182
14,182
9,000
9,154
6,096
Selling general and administrative
5,666
5,666
6,793
5,455
3,173
Total operating expenses
21,042
21,042
16,848
15,698
9,797
Operating income or loss
-20,050
-20,050
-15,612
-14,268
-8,960
Total other income/expenses net
-7.245
-7.245
160.726
-18.522
18.53
Income before tax
-20,057
-20,057
-15,451
-14,287
-8,942
Income tax expense
0
0
0
0
0
Income from continuing operations
-20,057
-20,057
-15,451
-14,287
-8,942
Net income
-20,057
-20,057
-15,451
-14,287
-8,942
Net income available to common shareholders
-20,057
-20,057
-15,451
-14,287
-8,942
Basic EPS
-1.59
-
-1.83
-2.24
-5.60
Diluted EPS
-1.59
-
-1.83
-2.24
-5.60
Basic average shares
12,914
-
8,439
6,370
1,599
Diluted average shares
12,914
-
8,439
6,370
1,599